IBDoc News

Successful Integration of IBDoc® into a Hospital Remote Monitoring System, using the standard HL7 communication pathway: Flarometer

An interview with Prof. Dr. Patrick Van RheenenUniversity Medical Center Groningen, The Netherlands Can you introduce yourself and your organization?My name is Patrick van Rheenen and work at the University Medical Centre in Groningen (the Netherlands). I am a clinical researcher into paediatric inflammatory bowel disease. How did you choose IBDoc® for the Flarometer project?Part of my research focusses on home telemonitoring. […]

Successful Integration of IBDoc® into a Hospital Remote Monitoring System, using the standard HL7 communication pathway: Flarometer Read More »

COVID-19 impact on IBD centers: IBDoc® success story and surveys

In 2020, the COVID-19 crisis had a high impact on the daily life of people all over the world. That is particularly true for patients with a chronic disease who must go to their hospital for regular follow-up visits. Inflammatory Bowel Disease (IBD) patients are no exception here. In order to face this extraordinary situation,

COVID-19 impact on IBD centers: IBDoc® success story and surveys Read More »

Fecal calprotectin- a small protein of high importance

Worldwide more than 6.8 million people live with Inflammatory Bowel Disease (IBD) which is characterized by chronic inflammation of the gastrointestinal tract. The highest numbers of IBD patients are observed in North America and Europe with an estimated 2.2 million affected persons in North America and an estimated 0.3% of the European population suffering from

Fecal calprotectin- a small protein of high importance Read More »

IBD and COVID-19

Because of the current situation with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the COVID-19 disease it is important to keep IBD patients out of clinics whenever possible. Nevertheless, tight monitoring of inflammation level in the gut is needed to deal with these chronic conditions. Calprotectin has proven to be an ideal

IBD and COVID-19 Read More »